Spyre Therapeutics, Inc. - Common Stock (SYRE) stock analysis
SYRE · Spyre Therapeutics, Inc. - Common Stock
Latest recorded price: USD 99.37
Sector and industry: Healthcare · Biotechnology
Fiscal 2025 figures: revenue growth -100.0%.
SYRE · Spyre Therapeutics, Inc. - Common Stock
Latest recorded price: USD 99.37
Sector and industry: Healthcare · Biotechnology
Fiscal 2025 figures: revenue growth -100.0%.